Clinical Trial Update: Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of FX006 for trochanteric bursitis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trochanteric Bursitis

Drugs mentioned

• FX006

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Trochanteric Bursitis | Phase 2 | Status: COMPLETED | Results posted: 2024-01-02